logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.
  • Medications for Dermatologic Disorders

    FiltersReset Filters
    9 results
    • analpram hc

      (hydrocortisone acetate and pramoxine hydrochloride)
      Sebela Pharmaceuticals Inc.
      Usage: Topical corticosteroids are used to relieve inflammation and itching associated with skin conditions that respond to corticosteroids.
    • clobetasol propionate

      (clobetasol propionate)
      IPG PHARMACEUTICALS, INC.
      Usage: Clobetasol propionate cream is indicated for relieving inflammatory and itchy symptoms of corticosteroid-responsive skin conditions. It should not be used for more than 2 weeks or exceed 50 g per week, especially in pediatric patients under 12, due to potential HPA axis suppression.
    • desonide

      (Desonide)
      Alembic Pharmaceuticals Inc.
      Usage: Desonide lotion is a low to medium potency corticosteroid used to relieve inflammation and itching associated with corticosteroid-responsive skin conditions.
    • diflorasone diacetate

      (Diflorasone Diacetate)
      Innovida Pharmaceutique Corporation
      Usage: Topical corticosteroids are indicated for relieving inflammation and itching associated with corticosteroid-responsive skin conditions.
    • fluocinonide

      (Fluocinonide)
      IPG PHARMACEUTICALS, INC.
      Usage: Fluocinonide Cream USP, 0.05% is indicated for relieving inflammation and itching associated with corticosteroid-responsive skin conditions.
    • fluocinonide

      (Fluocinonide)
      IPG PHARMACEUTICALS, INC.
      Usage: Fluocinonide Topical Solution USP, 0.05% is indicated for relieving inflammation and itching associated with corticosteroid-responsive skin conditions.
    • hydrocortisone

      (Hydrocortisone)
      ANI Pharmaceuticals, Inc.
      Usage: Topical corticosteroids are indicated for relieving inflammation and itching associated with corticosteroid-responsive skin conditions.
    • pramosone cream

      (hydrocortisone acetate and pramoxine hydrochloride)
      Sebela Pharmaceuticals Inc.
      Usage: Topical corticosteroids are indicated for the relief of inflammatory and itching symptoms associated with corticosteroid-responsive skin conditions.
    • texacort

      (Hydrocortisone)
      Mission Pharmacal Company
      Usage: Texacort Topical Solution 2.5% is indicated for relieving inflammation and itching associated with corticosteroid-responsive skin conditions.